Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulised frusemide in stable chronic heart failure
ACTRN12609000096257Phase 2Completed
- Sponsor
- St Vincent's Hospital
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of furosemide in heart failure (HF) (2 arms), sponsored by St Vincent's Hospital. Primary endpoint: Change in pulmonary artery wedge pressure. Started Aug 2006; status: completed.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ACTRN12609000096257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000096257.